Analyzing...
Loading company...
Intelligence analysis not yet available for this company.
Nothing flagged for monitoring
| (₹ Cr) | TTM | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|---|---|---|
| Other Income | ₹5 Cr +10.0% | ₹4 Cr 0.0% | ₹4 Cr -56.2% | ₹10 Cr 0.0% | ₹10 Cr +930.6% | ₹0.97 Cr 0.0% | ₹0.97 Cr -23.8% | ₹1 Cr |
| Total Income | ₹88 Cr -26.7% | ₹121 Cr 0.0% | ₹121 Cr -24.1% | ₹159 Cr 0.0% | ₹159 Cr -15.4% | ₹188 Cr 0.0% | ₹188 Cr -21.2% | ₹239 Cr |
| COGS | ₹38 Cr -36.1% | ₹60 Cr 0.0% | ₹60 Cr -16.3% | ₹71 Cr 0.0% | ₹71 Cr -73.7% | ₹272 Cr 0.0% | ₹272 Cr +76.9% | ₹153 Cr |
| ₹123 Cr -19.2% | ₹152 Cr 0.0% | ₹152 Cr -25.8% | ₹205 Cr 0.0% | ₹205 Cr -60.5% | ₹519 Cr 0.0% | ₹519 Cr +71.0% | ₹303 Cr | |
| Profit Before Tax | (₹34 Cr) -9.5% | (₹31 Cr) 0.0% | (₹31 Cr) +31.5% | (₹46 Cr) 0.0% | (₹46 Cr) +86.1% | (₹331 Cr) 0.0% | (₹331 Cr) -410.0% | (₹65 Cr) |
| ₹0.11 Cr 0.0% | ₹0.11 Cr 0.0% | ₹0.11 Cr ↑ Recovery | (₹0.38 Cr) 0.0% | (₹0.38 Cr) +82.2% | (₹2 Cr) 0.0% | (₹2 Cr) ↓ Decline | ₹3 Cr | |
| Net Profit | (₹34 Cr) -9.5% | (₹31 Cr) 0.0% | (₹31 Cr) +30.7% | (₹45 Cr) 0.0% | (₹45 Cr) +86.2% | (₹329 Cr) 0.0% | (₹329 Cr) -385.6% | (₹68 Cr) |
| Profit (Owners) | (₹34 Cr) -9.5% | (₹31 Cr) 0.0% | (₹31 Cr) +30.7% | (₹45 Cr) 0.0% | (₹45 Cr) +86.1% | (₹328 Cr) 0.0% | (₹328 Cr) -384.8% | (₹68 Cr) |
| EPS | (₹4.16) | (₹3.80) | (₹3.80) | (₹5.48) | (₹5.48) | (₹39.56) | (₹39.56) | (₹8.16) |
| Diluted Shares | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
Vivimed Labs Limited has informed regarding Disclosure of material issue
Vivimed Labs Limited has informed regarding Disclosure of material issue
Vivimed Labs Limited has informed regarding Disclosure of material issue
Vivimed Labs Limited has informed the Exchange about General Updates
The Exchange has sought clarification from Vivimed Labs Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation...
Vivimed Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Significant movement in price has been observed in Vivimed Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market pla...
Significant movement in price has been observed in Vivimed Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market pla...
Vivimed Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Revocation of Suspension in Trading of Equity Shares of Vivimed Labs LimitedWe are delighted to inform both exchanges, our valued shareholders, and market participants that BSE Limited and the Nationa...
Vivimed Labs Limited has submitted the Exchange a copy Srutinizers report of undefined held on December 10, 2025
Vivimed Labs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on December 10, 2025
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.